At a glance
- Originator AstraZeneca
- Class Antihypertensives; Anxiolytics; Small molecules
- Mechanism of Action Alpha 1 adrenergic receptor antagonists; Beta 2 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Arrhythmias
Most Recent Events
- 07 Apr 1999 Merger of Zeneca and Astra to form AstraZeneca completed